| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/17/2011 | CA2498944C Amino alcohol derivatives, salts thereof and immunosuppressive agents |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2440726C Substituted benzofuran-2-carboxamides derivatives |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2414484C Muscle-strengthening drugs and anti-inflammatory drugs |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/17/2011 | CA2397194C Alpha v integrin receptor antagonists |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/12/2011 | WO2011056972A2 Compositions and methods of treating a t cell mediated disorder |
| 05/12/2011 | WO2011056871A2 Rhamnolipid mechanism |
| 05/12/2011 | WO2011056604A2 Treatment of sunburn using analgesics and antihistamines |
| 05/12/2011 | WO2011056502A1 Bone morphogenetic protein receptor type ii compositions and methods of use |
| 05/12/2011 | WO2011056497A1 Activin receptor type iib compositions and methods of use |
| 05/12/2011 | WO2011056477A2 Methods for treating inflammation and oxidative stress related diseases |
| 05/12/2011 | WO2011056033A2 Pharmaceutical composition for preventing / treating trpv1 activity-related and inflammation-related diseases or conditions containing maillard peptide separated from well-aged traditional soy sauce as active ingredient |
| 05/12/2011 | WO2011055843A1 Retinoid compound |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011054922A1 Salts of fused pyrazine compounds, useful for the treatment of degenerative and inflammatory diseases. |
| 05/12/2011 | WO2011054846A1 Imidazo [4, 5-c] quinoline derivates as bromodomain inhibitors |
| 05/12/2011 | WO2011054844A1 Condensed azepine derivatives as bromodomain inhibitors |
| 05/12/2011 | WO2011054843A1 Bromodomain inhibitors for treating autoimmune and inflammatory diseases |
| 05/12/2011 | WO2011054828A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | WO2011054530A1 Gpbp inhibition using q2 peptidomimetics |
| 05/12/2011 | WO2011054315A1 Use of cyr61 protein for preparing medicine |
| 05/12/2011 | WO2011054171A1 Tyrosine derivative histone deacetylases inhibitors and applications thereof |
| 05/12/2011 | WO2010151735A3 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors |
| 05/12/2011 | WO2010147677A3 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112194 Medicaments Containing Pantothenic Acid |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112191 Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using same |
| 05/12/2011 | US20110112188 Treatment of Inflammatory Conditions |
| 05/12/2011 | US20110112183 Oligomer-Bis-Chromonyl Compound Conjugates |
| 05/12/2011 | US20110112182 Design, synthesis and functional characterization of rottlerin analogs |
| 05/12/2011 | US20110112181 Polyphenol compounds with modulating neurotransmitter release |
| 05/12/2011 | US20110112178 Compositions And Methods For Inhibiting Expression Of IKK-B Gene |
| 05/12/2011 | US20110112175 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112174 Peptide biosynthesis and pain therapy |
| 05/12/2011 | US20110112156 Bicyclic Derivatives as Modulators of Voltage Gated ION Channels |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112139 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112126 Enzyme inhibiting compounds |
| 05/12/2011 | US20110112119 Azabicyclooctyl-quinazolone derivatives useful as nicotinic acetylcholine receptor modulators |
| 05/12/2011 | US20110112106 Tricyclic inhibitors of 5-lipoxygenase |
| 05/12/2011 | US20110112102 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist |
| 05/12/2011 | US20110112093 Pyrimidinyl-piperazines useful as d3/d2 receptor ligands |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112083 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |
| 05/12/2011 | US20110112079 Phosphodiesterase inhibitors |
| 05/12/2011 | US20110112078 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 05/12/2011 | US20110112069 Purin derivatives for use in the treatment of fab-related diseases |
| 05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
| 05/12/2011 | US20110112064 Pyridyl Amide T-Type Calcium Channel Antagonists |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112055 Compositions and methods for treating colitis |
| 05/12/2011 | US20110112049 Methods of preventing or treating diseases and conditions using complex carbohydrates |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112011 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111073 Recovery of hydrophobic peptides from oils |
| 05/12/2011 | US20110111070 Use of phy906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome |
| 05/12/2011 | US20110111059 Compositions Comprising Quinazoline Derivatives, Preparation Methods and Uses Thereof |
| 05/12/2011 | US20110111050 Herbal medicinal composition and herbal medicinal extract for inducing production of peripheral blood stem cells and method for preparing the same |
| 05/12/2011 | US20110111044 Nanoparticle compositions for nucleic acids delivery system |
| 05/12/2011 | US20110111042 Self-microemulsifying systems incorporated into liquid core microcapsules |
| 05/12/2011 | US20110111035 Inflammation-regulating compositions and methods |
| 05/12/2011 | US20110111013 Transdermal therapeutic system for administration of fentanyl or an analogue thereof |
| 05/12/2011 | US20110111007 Inhibition of retinal cell degeneration or neovascularization by cerium oxide nanoparticles |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110110950 Therapeutic regimens for BAFF antagonists |
| 05/12/2011 | US20110110948 Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110943 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110930 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects |
| 05/12/2011 | US20110110928 Fc variants with altered binding to fcrn |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110915 14189, a novel human kinase and uses thereof |
| 05/12/2011 | US20110110910 Proteases for Pharmaceutical Use |
| 05/12/2011 | US20110110907 Composition of soluble indigestible fibers and of eukaryotic organisms with a polysaccharide wall, used in the well-being field |
| 05/12/2011 | US20110110885 Bioactive Depside and Anthocyanin Compounds, Compositions, and Methods of Use |
| 05/12/2011 | US20110110884 Immunotherapy for immune suppressed patients |
| 05/12/2011 | US20110110855 Novel ghrelin analogues |
| 05/12/2011 | CA2779935A1 Heterocyclic sulfonamide derivatives useful as mek inhibitors |
| 05/12/2011 | CA2778825A1 Treatment of sunburn using analgesics and antihistamines |
| 05/12/2011 | CA2774046A1 Compositions comprising phenylsulfamic acids and their use for treating colitis |
| 05/11/2011 | EP2319846A1 Process for preparing oxycodone hydrochloride having less than 25ppm 14-hydroxycodeinone |
| 05/11/2011 | EP2319840A1 Aminopropylidene derivative |
| 05/11/2011 | EP2319839A1 Quinazolinone derivatives and their use as CB agonists |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319585A1 Pharmaceutical products and compositions comprising salmeterol, fluticasone and ipratropium or tiotropium |
| 05/11/2011 | EP2319584A1 Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium |
| 05/11/2011 | EP2319583A1 Pharmaceutical products and compositions comprising salmeterol, budesonide and ipratropium |
| 05/11/2011 | EP2319582A1 Pharmaceutical products and compositions comprising formoterol, budesonide and tiotropium or oxitropium |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2319519A1 Composition for inhibiting expression of target gene |
| 05/11/2011 | EP2319518A1 Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |